Infimer Financial Statements From 2010 to 2024
| INFR Stock | ILA 1.50 24,498 99.99% |
Check Infimer financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Infimer's main balance sheet or income statement drivers, such as , as well as many indicators such as . Infimer financial statements analysis is a perfect complement when working with Infimer Valuation or Volatility modules.
Infimer |
Infimer Company Current Valuation Analysis
Infimer's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Infimer Current Valuation | 25.15 M |
Most of Infimer's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Infimer is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Infimer has a Current Valuation of 25.15 M. This is 99.65% lower than that of the Chemicals sector and 99.73% lower than that of the Materials industry. The current valuation for all Israel stocks is 99.85% higher than that of the company.
Infimer Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Infimer's current stock value. Our valuation model uses many indicators to compare Infimer value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Infimer competition to find correlations between indicators driving Infimer's intrinsic value. More Info.Infimer is rated second overall in return on asset category among its peers. It also is rated second overall in operating margin category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Infimer by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Infimer's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About Infimer Financial Statements
Infimer stakeholders use historical fundamental indicators, such as Infimer's revenue or net income, to determine how well the company is positioned to perform in the future. Although Infimer investors may analyze each financial statement separately, they are all interrelated. For example, changes in Infimer's assets and liabilities are reflected in the revenues and expenses on Infimer's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Infimer. Please read more on our technical analysis and fundamental analysis pages.
Infimer Ltd develops technology and production processes for converting municipal solid waste. The company was founded in 2013 and is based in Avihayil, Israel. INFIMER operates under Waste Management classification in Israel and is traded on Tel Aviv Stock Exchange. It employs 23700 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Infimer Stock
Infimer financial ratios help investors to determine whether Infimer Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Infimer with respect to the benefits of owning Infimer security.